Curis Consents First Six Patients in TakeAim CLL Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. IQMX
4. SPY
5. EROC
6. MSFT
7. MSTR
8. SEER
9. FRBT
10. USO

Go back to Curis Consents First Six Patients in TakeAim CLL Study
Curis, Inc. (NASDAQ: CRIS) Delayed: 6.33 +5.98 (1,708.57%)
Previous Close $0.35    52 Week High $3.70 
Open $6.53    52 Week Low $1.25 
Day High $6.74    P/E N/A 
Day Low $6.09    EPS $-0.15 
Volume 80,351